Skip to content
Screener

Evolus EOLS Market capitalization

Market capitalization at other companies

AbbVie logo
AbbVieABBV
$444.6B+35.6%

Other financials

Income statement

See full
Revenue$84.1M+21.2%
Gross profit$57.2M+26.2%
Operating income-$4.5M+55.5%
Net income-$8.1M+53.0%
EPS (diluted)-$0.12+55.6%

Balance sheet

See full
Cash & equivalents$45.2M-26.8%
Total debt$164.8M+12.3%
Total equity-$30.9M-65.7%
Total assets$248.0M+8.4%

Cash flow

See full
Operating cash flow-$3.6M+85.5%
CapEx$50.0K-92.7%
Free cash flow-$3.6M+85.7%

Valuation

See full
Enterprise value$620.96M+33.1%
P/S1.6×+0.2×

Profitability

See full
Gross margin66.7%-0.4pp
Operating margin-13.7%-1.9pp
Net margin-10.9%-3.7pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio1.7×-0.6×

Where this comes from

Computed from the period-end share price: $457.03M.

The source filing: Evolus’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053468

FAQ

What is Evolus's market capitalization?
Evolus (EOLS) reported market capitalization of $457.03M in Q2 2026.
How has Evolus's market capitalization changed year-over-year?
Evolus's market capitalization decreased by 26.3% year-over-year, from $620.26M to $457.03M.
What is the long-term trend for Evolus's market capitalization?
Over 5 years (2020 to 2025), Evolus's market capitalization has grown at a 18.2% compound annual growth rate (CAGR), from $186.74M to $431.05M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Evolus's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude